iBio IBIO
NASDAQ IBIO
$1.17 +0.00 (+0.00%)
As of: Sep 30, 2026 · 3:59 PM EDT

iBio (IBIO) Gross Margin (2020 - 2022)

Updated

iBio (IBIO) reported Gross Margin of 115.02% for FY2022 (year ended Jun 30, 2022), up 76.68 percentage points from 38.34% in FY2021.

Analysis

iBio (IBIO) Gross Margin (2020 - 2022) Analysis & Trends

  • According to Business Quant data, Gross Margin came in at 38.34% in FY2021 (-18.74 pp) and 57.08% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 68.19%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 74.74%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 73.54%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 78.02%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 83.60%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 72.04%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 85.33%
10 iBio 121.75 Mn 121.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 105.28%
Sep 30, 2021 203.57%
Jun 30, 2021 61.91%
Mar 31, 2021 35.56%
Dec 31, 2020 70.07%
Sep 30, 2020 73.90%
Jun 30, 2020 73.30%
Mar 31, 2020 10.42%
API Access

iBio Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=IBIO&period=max&api_key=YOUR_API_KEY